| |
original article |
Date |
Title |
Authors All Authors |
| 1 |
[GO] |
2022―Nov―23 |
Thwarting coronavirus infections by tapping host targets: The ‘Greek gift sacrifice’ to curb the menace of drug resistance |
Pobitra Borah, Sangeeta Hazarika |
| 2 |
[GO] |
2022―Sep―12 |
COVID-19 and diabetes: will novel drugs for diabetes help in COVID-19? |
Pranav Kumar Prabhakar, Gaber El-Saber Batiha, Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Gomaa Mostafa-Hedeab, Rupal Dubey |
| 3 |
[GO] |
2022―Jan―13 |
Polysaccharides to combat viruses (Covid-19) and microbes: New updates |
Manaf AlMatar, Essam A. Makky, Aizi Nor Mazila Ramli, Nesibe Ebru Kafkas, Fatih Köksal |
| 4 |
[GO] |
2021―Oct―14 |
Pharmacotherapy for SARS-CoV-2 and Seizures for drug repurposing presumed on Mechanistic Targets |
Divya Goel, Ankit Srivastava, Ángel Aledo-Serrano, Anuja Krishnan, Divya Vohora |
| 5 |
[GO] |
2021―Sep―07 |
Structural Understanding of SARS-CoV-2 Drug Targets, Active Site Contour Map Analysis and COVID-19 Therapeutics |
Chandrabose Selvaraj, Dhurvas Chandrasekaran Dinesh, Petra Krafcikova, Evzen Boura, Murali Aarthy, Muthuraja Arun Pravin, Sanjeev Kumar Singh |
| 6 |
[GO] |
2021―Sep―03 |
Impact of Sitagliptin in Non-Diabetic Covid-19 Patients |
Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Naeem Qusty, Athanasios Alexiou, Gaber El-Saber Batiha |
| 7 |
[GO] |
2021―Aug―12 |
Comprehensive analysis of SARS-COV-2 drug targets and pharmacological aspects in treating the COVID-19 |
Sundaresan Bhavaniramya, Vanajothi Ramar, Selvaraju Vishnupriya, Ramasamy Palaniappan, Ashokkumar Sibiya, Vaseeharan Baskaralingam |
| 8 |
[GO] |
2020―Sep―01 |
COVID-19: Pathophysiology; Mechanism of Transmission and Possible Molecular Drug Target for Management |
Asis Bala, Abhijit Sengupta, Motlalepula Gilbert Matsabisa, Hlupheka P Chabalala |
